Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Atadja, BioNJ, British, Calgary, chemistry, Clarke, CommBio, Eli, Ghana, Hebrew, Imperial, Innovation, Kumasi, Lilly, Liverpool, organic, passed, Peter, PharmaCyte, Site, superseded, Trafford, UK
Removed:
additionally, auditor, Baptist, compatible, devastating, inadequate, maintaining, Northwestern, rendered, targeted
Filing tables
Filing exhibits
Associated TRAW transcripts
TRAW similar filings
Filing view
External links
Exhibit 31.1
CERTIFICATIONS
I, Steven M. Fruchtman, certify that:
1. I have reviewed this Annual Report on Form 10-K/A of Onconova Therapeutics, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
| |
Dated: May 1, 2023 |
|
| |
|
|
/s/ STEVEN M. FRUCHTMAN, M.D. | |
Steven M. Fruchtman M.D. | |
President and Chief Executive Officer | |
(Principal Executive Officer) | |